NCT00005006View on ClinicalTrials.gov

Parathyroid Hormone (PTH) With Alendronate for Osteoporosis

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 30, 1987

Primary Completion Date

February 28, 2003

Study Completion Date

December 31, 2006

Conditions
Osteoporosis
Interventions
DRUG

Parathyroid Hormone

Alendronate 70mg/week; Teriparatide 20mcg/ day

DRUG

Alendronate

Alendronate 70mg/week

DRUG

Teriparatide

Teriparatide 20mcg/day

Trial Locations (1)

10993

Helen Hayes Hospital, Clinical Research Center, West Haverstraw

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Helen Hayes Hospital

OTHER

NCT00005006 - Parathyroid Hormone (PTH) With Alendronate for Osteoporosis | Biotech Hunter | Biotech Hunter